DLL4 promotes partial endothelial-to-mesenchymal transition at atherosclerosis-prone regions of arteries
Vascular Pharmacology · 2023
DOI: 10.1016/j.vph.2023.107178 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vascular Pharmacology, 2023. Verfasst von Xiuying Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China; School of Pharmacy, Southwest Medical …. Hauptthemen laut MEDLINE: Coronary Vessels, Endothelial Cells, Atherosclerosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: British Heart Foundation, National Natural Science Foundation of China, Sichuan Province Science and Technology Support Program.
Abstract (Originalsprache)
Flowing blood regulates vascular development, homeostasis and disease by generating wall shear stress which has major effects on endothelial cell (EC) physiology. Low oscillatory shear stress (LOSS) induces a form of cell plasticity called endothelial-to-mesenchymal transition (EndMT). This process has divergent effects; in embryos LOSS-induced EndMT drives the development of atrioventricular valves, whereas in adult arteries it is associated with inflammation and atherosclerosis. The Notch ligand DLL4 is essential for LOSS-dependent valve development; here we investigated whether DLL4 is required for responses to LOSS in adult arteries. Analysis of cultured human coronary artery EC revealed that DLL4 regulates the transcriptome to induce markers of EndMT and inflammation under LOSS conditions. Consistently, genetic deletion of Dll4 from murine EC reduced SNAIL (EndMT marker) and VCAM-1 (inflammation marker) at a LOSS region of the murine aorta. We hypothesized that endothelial Dll4 is pro-atherogenic but this analysis was confounded because endothelial Dll4 negatively regulated plasma cholesterol levels in hyperlipidemic mice. We conclude that endothelial DLL4 is required for LOSS-induction of EndMT and inflammation regulators at atheroprone regions of arteries, and is also a regulator of plasma cholesterol.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, PR China; School of Pharmacy, Southwest Medical University, LuZhou, Sichuan 646000, PR China; Department of Infection,…
- Department of Infection, Immunity and Cardiovascular Disease, INSIGNEO Institute, Bateson Centre, University of Sheffield, UK. Electronic address: c.souilhol@shu.ac.uk.
- Department of Infection, Immunity and Cardiovascular Disease, INSIGNEO Institute, Bateson Centre, University of Sheffield, UK.
- Department of Infection, Immunity and Cardiovascular Disease, INSIGNEO Institute, Bateson Centre, University of Sheffield, UK; Centre for Biochemical Pharmacology, William Harvey Research Institute, Barts and The London…
Förderung
- British Heart Foundation
- National Natural Science Foundation of China
- Sichuan Province Science and Technology Support Program
Zitieren
APA
Li, X., Souilhol, C., Canham, L., Jia, X., Diagbouga, M., Ayllon, B. T., Serbanovic-Canic, J., & Evans, P. C. (2023). DLL4 promotes partial endothelial-to-mesenchymal transition at atherosclerosis-prone regions of arteries. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2023.107178
Vancouver
Li X, Souilhol C, Canham L, Jia X, Diagbouga M, Ayllon BT, et al. DLL4 promotes partial endothelial-to-mesenchymal transition at atherosclerosis-prone regions of arteries. Vascular Pharmacology. 2023. doi:10.1016/j.vph.2023.107178
BibTeX
@article{Li2023,
author = {Li, Xiuying and Souilhol, Celine and Canham, Lindsay and Jia, Xueqi and Diagbouga, Mannekomba and Ayllon, Blanca Tardajos and Serbanovic-Canic, Jovana and Evans, Paul C},
title = {DLL4 promotes partial endothelial-to-mesenchymal transition at atherosclerosis-prone regions of arteries},
journal = {Vascular Pharmacology},
year = {2023},
doi = {10.1016/j.vph.2023.107178}
}
EUVIMED